Fig. 2: Time to event by tertile of IL-6, IL-17A, MDC/CCL22, and VEGF-A level.
From: Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer
Kaplan–Meier plots of time to distant recurrence for (A) IL-6 (B), IL-17A, (C) MDC/CCL22, and (D) VEGF-A. All Kaplan–Meier plots show time to distant recurrence by low (≤33rd percentile), intermediate (34th–66th percentile), and high (>66th percentile) biomarker results.
